论文部分内容阅读
对采用ＣＴ导向立体定向血肿抽吸术治疗（新疗法）和内科保守治疗的高血压性丘脑一底节区脑出血各４６例进行１：ｌ配对对照研究。结果发现新疗法的近期疗效明显优于旧疗法，表现在：①明显提高重型脑出血的治愈好转率（Ｐ＜０，０５）；②对中型脑出血、血肿量在６０～１２０ｍｌ的患者不但能降低病死率，而且能显著提高治愈好转率（Ｐ＜０．０１）；③降低中线移位者的病死率（ｐ＜０．０５）。但对轻型脑出血，血肿量在３０～６０ｍｌ的患者新旧疗法疗效相似。故主张对中重型脑出血，血肿量在６０～１２０ｍｌ的患者，急救应首选ＣＴ导向立体定向血肿抽吸术。
Forty-six hypertensive hypothalamic-intracerebral hemorrhage patients treated with CT-guided stereotactic hematoma aspiration (new therapy) and conservative medical treatment were studied in 1: 1 matched controls. The results showed that the short-term curative effect of the new therapy was significantly better than the old therapy, manifested in: ① significantly improve the cure rate of severe intracerebral hemorrhage (P <0,05); ② for medium cerebral hemorrhage, hematoma in 60 ~ 120ml patients not only Reduce mortality, and can significantly improve the cure rate (P <0.01); ③ reduce the median shift of the mortality (p <0.05). However, mild to intracerebral hemorrhage, hematoma in patients with 30 ~ 60ml old and new therapies have similar efficacy. Therefore advocated on the type of severe intracerebral hemorrhage, hematoma in 60 ~ 120ml of patients, the first choice should be the preferred CT-guided stereotactic hematoma aspiration.